Abstract
Background: Chest pain is the second most frequent cause of presentation for management. Selection of the proper technique for chest pain diagnosis is crucial. Coronary computed tomography angiography (CCTA) is considered an early chest pain diagnostic procedure.
Aim: To evaluate outcomes of early use of CCTA in our Jordanian group of patients.
Methods: Our retrospective investigation included 485 patients, aged 18–74 years, of both sexes, with low-risk chest pain but no history of coronary artery disease. All patients were assigned to CCTA at King Hussein Hospital, King Hussein Medical Center, Amman, Jordan, during the 2017–2018 period. The primary outcome was secondary cardiac catheterization. The secondary outcome was cardiovascular hazards. Correlation between sex, age, and body mass index, was recorded using the χ2 or Fisher’s exact test. Correlation between chest pain and cardiovascular findings was recorded using the χ2 or Fisher’s exact test. P-values of less than 0.05 were recorded as significant.
Results: Normal CCTA was recorded in 324 patients (66.8%). Secondary cardiac catheterization was performed in 161 patients (33.2%), of whom 68 patients (68/485 = 14.02%) had percutaneous coronary interventions. There were 17 (17/485 = 3.5%) cardiovascular hazards within a median of one year after CCTA.
Conclusions: To treat a patient with heart disease, the first step is to determine whether he or she has coronary artery disease. The second step is to determine whether the coronary artery disease is remarkable, requiring choosing between conservative management or revascularization. If the patient has remarkable coronary artery disease, the third step is to determine whether the patient requires percutaneous intervention or CABG, taking into consideration the clinical characteristics of the patient such as age, comorbidity, and individual risk.
Keywords: low-risk chest pain; coronary computed tomography angiography; outcome: primary, secondary.
JRMS December 2023; 30 (3): 10.12816/0061661
Angina-like retrosternal chest
pain may originate from cardiovascular or noncardiovascular causes because of
the common sensory innervation of the heart, pleura, aorta and esophagus by
fibers from the same spinal segments. Nowadays, in low-to-intermediate risk
patients, CCTA can exclude coronary origin of chest pain. This permits many
patients with nonsignificant coronary artery disease at CCTA to avoid conventional coronary angiography (4).
The
aim of our investigation was to evaluate outcome of early use of CCTA in our
Jordanian group of patients.
Methods
Our retrospective investigation included 485
patients, aged 18–74 years, of both sexes, with low-risk chest pain but with no
history of coronary artery disease. All patients were assigned to CCTA at King Hussein Hospital, King Hussein Medical
Center (KHMC), Amman, Jordan, during the 2017–2018 period after obtaining
approval from the local ethical and research board review committee of JRMS(Jordanian
royal medical services), KHMC, Amman, Jordan. Inclusion criteria were as
follows: negative serum troponin level 6 h after onset of clinical features and
consequent disappearance of chest pain. Exclusion criteria were as follows:
increased serum troponin T, electrocardiogram changes of acute ischemia or
myocardial infarction, persistent chest pain, renal insufficiency, active
asthma, and CCTA performed during the past six months.
All participants were scheduled according to
low-risk chest pain for CCTA. The patients imaged via SIMENS CT (Somatom Force)
256-slice in the Radiology department, All patients were examined by two
Radiology specialist in two separate sessions and the results were analyzed by
simple statistical methods. Patients
with positive findings were assigned to cardiac catheterization. Patients were
divided according to invasive therapy in revascularization and no
revascularization groups. The primary outcome was secondary cardiac
catheterization. The secondary outcome was cardiovascular hazards (myocardial
infarction and cerebrovascular accident), including severe hazards for the
revascularization group. Outcomes were assessed at one month and one year.
Statistics
Correlation
between sex, age, and BMI was recorded using the χ2 or Fisher’s
exact test. Correlation between chest pain and cardiovascular findings was
recorded using the χ2 or Fisher’s exact test. P values of less than
0.05 were recorded as significant.
Results
Median age of patients was 46 years, with 199
females (41.03%) (Table I). Normal CCTA was recorded in 324 patients (66.8%).
Secondary cardiac catheterization was performed in 161 patients (33.2%), out of
whom 68 patients (68/485 = 14.02%) had percutaneous coronary interventions. Ten
patients (2.1%) had CABG(coronary artery bypass graft). There were 17 (17/485 =
3.5%) cardiovascular hazards within a median of one year after CCTA. There were
significant differences between incidences of myocardial infarction and cerebrovascular
accidents (P < 0.005).
Twelve CCTA patients (2.5%) experienced severe
hazards of coronary revascularization (Table II). Eight-three CCTA patients
(17.1%) did not have revascularization. There were no significant difference
between percentage of revascularization and no revascularization during cardiac
catheterization (P > 0.05) (Table II). One hundred and forty CCTA patients
(28.9%) had persistent chest pain or shortness of breath. There were no
significant differences regarding incidences of severe hazards of
revascularization between types of chest pain (P > 0.05) (Table III).
Table I. Patient demographics.
Item
|
No (%)
|
Age (yrs.) median
(range)
|
46 (18-74)
|
Body mass index (kg/m2)
median
|
27
|
Sex M
F
|
286 (58.97)
199 (41.03)
|
Postmenopausal
|
130 (26.8)
|
Coronary artery
disease family history
|
170 (35.1)
|
Medical history
Hypertension
Diabetes mellitus
|
250 (51.5)
150 (30.9)
|
Smoking
|
120 (24.7)
|
Sedentarism
|
350 (72.2)
|
Acetylsalicylic acid
|
120 (24.7)
|
Chest pain By effort
Retrosternal
Relieved by rest or
nitroglycerin
|
90 (18.6)
380 (78.4)
240 (49.5)
|
Table II. Postprocedural hazards and secondary procedures.
Hazards
|
No (%)
|
Cardiovascular myocardial
infarction
Cerebrovascular accident
|
14 (2.9)
3 (0.6)
|
Secondary procedures
|
|
Cardiac catheterization
Revascularization
CABG
PCI
No revascularization
|
161 (33.2)
78 (16.1)
10 (2.1)
68 (14.2)
83 (17.1)
|
Severe hazards
|
|
Revascularization
|
12(2.5)
|
Table III. Correlation between chest pain and investigation
findings.
Chest pain
|
By effort (n = 90)
|
Retrosternal (n = 380)
|
Relieved by GTN (n = 240)
|
Myocardial infarction
(n = 14)
|
2
|
7
|
5
|
CABG (n = 10)
|
3
|
3
|
4
|
PCI (n = 68)
|
36
|
10
|
22
|
No revascularization
(n = 83)
|
23
|
41
|
19
|
Severe hazards of
revascularization (n = 12)
|
4
|
4
|
4
|
Discussion
The
diagnosis of cardiac and coronary diseases is being influenced by the
application of new radiological methods. CCTA allows direct anatomical
recognition of atherosclerotic stenosis in the epicardial coronary arteries,
with low radiation exposure. Increased heart rate, dysrhythmia, obesity and
increased coronary calcium size can limit total assessment. CCTA has an increased diagnostic
precision compared with invasive coronary angiography.
We conducted an assessment of CCTA in low-risk
chest pain patients. In our investigation, CCTA was conducted earlier and at
the same moment in the diagnostic work-up. Cardiac catheterization was
performed late in patients in CCTA (5). We showed that most catheterized
patients did not undergo a coronary procedure. Although a previous study
demonstrated a slight reduction in catheterizations without procedures with CCTA, it also demonstrated increased total percentage of
catheterization, percutaneous intervention, and bypass surgery (6).
Increased revascularization in CCTA patients was found in other patients (4).
There were
more aspirin prescriptions in CCTA because of the
greater percentage of patients with coronary artery disease (7).
There was also a significant reduction in myocardial infarction in
patients undergoing CCTA due to the availability of enhanced medical therapy
guidelines (8,9).
This investigation was a single-center
investigation, which limited generalization. Therefore, the application of the
results of this investigation in other centers will rely on the availability of
imaging techniques. Our investigation was not intended to detect cardiovascular
hazards (6).The
potential reduction in imaging relies on the multiple triage system used (10). The proper management method to
improve outcomes of patients with low troponin levels is still being debated (11).
We did not evaluate the effects of advances in CCTA, especially procedures for
detection of stenosis significance. Pretest probability of severe coronary
disease was detected (12).
Our
investigation focused on low-risk patients, and this fact must be taken into
account before applying the results to high-risk patients.
CCTA is the only diagnostic
method that can recognize nonobstructive coronary plaque disease. Standard
noninvasive ischemia testing methods have poor sensitivity for obstructive
coronary disease and cannot differentiate patients with normal coronary
arteries from those with nonobstructive plaque disease. Recognition of nonobstructive
coronary disease is the key for prophylactic treatments in patients undergoing
CCTA.
Conclusions
To treat a
patient with heart disease, the first step is to determine whether he or she
has coronary artery disease. The second step is to determine whether the
coronary artery disease is remarkable, requiring choosing between conservative
management and revascularization. If the patient has remarkable coronary artery
disease, the third step is to determine whether the patient requires percutaneous
intervention or CABG, taking into consideration the clinical characteristics of
the patient such as age, comorbidity, and individual risk.
References
1. SCOT-HEART
Investigators, Newby DE, Adamson PD, Berry C, et al. Coronary
CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018 6;379(10):924–33.
2. Udo H, Quynh AT,
David AS, et al. Coronary CT angiography
versus standard evaluation in acute chest pain. N Engl J Med. 2012;367:299–3082. Udo H, Quynh AT, David AS, et al. Coronary CT angiography versus standard evaluation in acute chest pain. N
Engl J Med. 2012;367:299–308.
3.
SCOT-HEART
Investigators. CT coronary angiography in patients with
suspected angina due to coronary heart disease (SCOT-HEART): An open-label,
parallel-group, multicentre trial. Lancet. 2015 Jun 13;385(9985):2383–91.
4. Patrizia CA, Igoren G, Giuseppe M, et al. Prognostic
value and therapeutic perspectives of coronary CT angiography: A literature
review. BioMed Res Int. 2018.
5. Piers
LH, Dikkers
R, Willems
TP, et al. Computed tomographic angiography or
conventional coronary angiography in therapeutic decision-making. Eur Heart J. 2008 December 29(23):2902–7.
6. Wu Z, He Y, Li W, et al.
Computed tomography coronary angiography vs. standard diagnostic procedure for
the diagnosis of angina due to coronary heart disease: A cross-sectional study.
Exp Ther Med. 2019
April;17(4):2485–94.
7. Foy AJ, Dhruva B. Peterson SS, Mandrola JM, Morgan DJ, Redberg RF.
Coronary computed tomography angiography vs. functional stress testing for
patients with suspected coronary artery disease: A systematic review and
meta-analysis.
JAMA Intern Med. 2017;177:1623–31.
8. Levsky
JM, Haramati
LB, Spevack
DM, et al. Coronary computed tomography angiography versus
stress echocardiography in acute chest pain: A randomized controlled trial.
JACC Cardiovasc Imaging. 2018 Septemper;11(9):1288–97.
9. Silvia T, Anna R, Sara S, et al. Computed
tomography coronary angiography in patients without known coronary artery
disease can demonstrate possible non-cardiovascular causes of non-acute
retrosternal chest pain. Insights Imaging.
2018;9(5):687–94.
10. Robert H, Peter S, Pascal GT, et al. Diagnosis of obstructive coronary artery
disease using computed tomography angiography in patients with stable chest
pain depending on clinical probability and in clinically important subgroups:
Meta-analysis of individual patient data. BMJ. 2019;365:l1945.
11. Jeffrey ML, Linda BH, Daniel MS, et al. Coronary computed tomography angiography versus
stress echocardiography in acute chest pain: A randomized controlled trial.
JACC. 2018;11(9):1288–97.
12. Moscariello
A, Vliegenthart
R, Schoepf
UJ, et al. Coronary CT angiography versus conventional
cardiac angiography for therapeutic decision making in patients with high
likelihood of coronary artery disease. Radiology. 2012 November ;265(2):385–92.